It's hard to figure out what has happened.
Revenue is up, but EBITDA is down in both video and wearables (note Australia revenue is down for wearables). Profit is really far down.
Employee costs almost doubled, maybe this is the cause? It's the only area where I see significant increase in cost. (Cost of production increasing is to be expected, given expansion of Prosumer)
Is it also bad their depreciation and amortisation is accelerating faster than their revenue growth?
- Forums
- ASX - By Stock
- CAT
- Ann: CAT reports solid H1 performance, reaffirms FY18 guidance
CAT
catapult group international ltd
Add to My Watchlist
0.00%
!
$5.80

Ann: CAT reports solid H1 performance, reaffirms FY18 guidance, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.80 |
Change
0.000(0.00%) |
Mkt cap ! $1.645B |
Open | High | Low | Value | Volume |
$5.88 | $5.88 | $5.73 | $4.453M | 768.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 450 | $5.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.80 | 2500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 200 | 5.740 |
2 | 2240 | 5.700 |
1 | 3 | 5.670 |
1 | 495 | 5.650 |
1 | 15078 | 5.630 |
Price($) | Vol. | No. |
---|---|---|
5.800 | 2500 | 1 |
5.820 | 6024 | 1 |
5.900 | 550 | 1 |
5.950 | 9110 | 4 |
6.000 | 26527 | 10 |
Last trade - 16.17pm 04/07/2025 (20 minute delay) ? |
Featured News
CAT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online